|
?:authorAffiliation
|
-
[\'Jenny S. Guadamuz is a postdoctoral fellow in the Program on Medicines and Public Health in the Titus Family Department of Clinical Pharmacy and the Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California School of Pharmacy, in Los Angeles, California.\', \'Jocelyn R. Wilder is a PhD candidate in the Department of Epidemiology, University of Illinois at Chicago, in Chicago, Illinois.\', \'Morgane C. Mouslim is a policy analyst at the Hilltop Insititute, University of Maryland Baltimore County, in Baltimore, Maryland.\', \'Shannon N. Zenk is director of the National Institute of Nursing Research, National Institutes of Health, in Bethesda, Maryland. She was a professor in the Department of Population Health Nursing Science, University of Illinois at Chicago, when this work was conducted.\', \'G. Caleb Alexander is a professor in the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, and codirector of the school\'s Center for Drug Safety and Effectiveness, in Baltimore, Maryland.\', \'Dima Mazen Qato (qato@usc.edu) is an associate professor at the University of Southern California School of Pharmacy, senior fellow at the Leonard D. Schaeffer Center for Health Policy and Economics, and director of the school\'s Program on Medicines and Public Health.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}